InvestorsObserver
×
News Home

Will Mirati Therapeutics Inc (MRTX) Outperform the Rest of the Stocks in the Healthcare Sector?

Thursday, September 22, 2022 02:58 PM | InvestorsObserver Analysts
Will Mirati Therapeutics Inc (MRTX) Outperform the Rest of the Stocks in the Healthcare Sector?

Mirati Therapeutics Inc (MRTX) is near the top in its sector according to InvestorsObserver. MRTX gets an overall rating of 86. That means it scores higher than 86% of stocks. Mirati Therapeutics Inc gets a 93 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 86
MRTX has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on MRTX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 86 means the stock is more attractive than 86 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Mirati Therapeutics Inc Stock Today?

Mirati Therapeutics Inc (MRTX) stock is trading at $68.92 as of 2:57 PM on Thursday, Sep 22, a loss of -$2.78, or -3.88% from the previous closing price of $71.70. The stock has traded between $67.37 and $71.49 so far today. Volume today is 845,956 compared to average volume of 825,954. Click Here to get the full Stock Report for Mirati Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App